Cargando…
The science of rapid start—From the when to the how of antiretroviral initiation
In this Perspective linked to Koenig and colleagues, Elvin Geng and Diane Havlir discuss the next challenges for implementation research around rapid start antiretroviral treatment.
Autores principales: | Geng, Elvin H., Havlir, Diane V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5526524/ https://www.ncbi.nlm.nih.gov/pubmed/28742819 http://dx.doi.org/10.1371/journal.pmed.1002358 |
Ejemplares similares
-
When to Start Antiretroviral Therapy
por: Jain, Vivek, et al.
Publicado: (2010) -
Initiating insulin: How to help people with type 2 diabetes start and continue insulin successfully
por: Polonsky, William H., et al.
Publicado: (2017) -
How to start a biotech company
por: Tajonar, Adriana
Publicado: (2014) -
Understanding uptake of an intervention to accelerate antiretroviral therapy initiation in Uganda via qualitative inquiry
por: Semitala, Fred C, et al.
Publicado: (2017) -
When to start antiretroviral therapy: as soon as possible
por: Franco, Ricardo A, et al.
Publicado: (2013)